Science Explorer Interactive view Map
Research facility · Silver Spring · United States

Center for Drug Evaluation and Research

In research, Center for Drug Evaluation and Research stands highest in Medicine (#871 of 10,443 worldwide), Health Sciences (#1,287 of 11,982 worldwide) and Life Sciences (#1,577 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Pharmaceutical Science, Statistics and Probability and Pharmacology, Toxicology and Pharmaceutics — Pharmaceutical Science is 34.3× its share of world research.

World rank, 2022–2025
#2,842
of 28,054 · #1,985 all time
Rank in United States
#411
of 4,192
Research works
3.6k
▲ 15% vs 2013–17
Citations
148k
41.5 per fractional work
Top-10% rate
29.4%
record average 16.5%
Open access
36%
world 28%

What is Center for Drug Evaluation and Research known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #871 of 10,443 32.9%282 #591
Health SciencesDomain #1,287 of 11,982 32.4%296 #778
Life SciencesDomain #1,577 of 7,800 22.9%171 #1114
Physical SciencesDomain #8,030 of 12,888 28.0%106 #7338
Biochemistry, Genetics and Molecular BiologyField #2,299 of 3,579 26.2%82 #1740

Each strip is that field’s whole ranked pool, with the notch where Center for Drug Evaluation and Research sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Medicine#591 #871
  2. Health Sciences#778 #1,287
  3. Life Sciences#1,114 #1,577
  4. Physical Sciences#7,338 #8,030
  5. Biochemistry, Genetics and Molecular Biology#1,740 #2,299
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Center for Drug Evaluation and Research specialise in?

Where its research is concentrated relative to its size: Pharmaceutical Science takes 34.3× the share of its output that it takes of world research.

  1. Pharmaceutical ScienceSubfield · 22.8 works34×
  2. Statistics and ProbabilitySubfield · 37.5 works28×
  3. Pharmacology, Toxicology and PharmaceuticsField · 51.3 works23×
  4. Pediatrics, Perinatology and Child HealthSubfield · 27.5 works5.9×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 6 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.47× its world share, 82 worksBiochemistry, Geneti…Immunology and Microbiology: 3.79× its world share, 24 worksImmunology and Micro…Neuroscience: 0.74× its world share, 8 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 23.30× its world share, 51 worksPharmacology, Toxico…Chemical Engineering: 0.36× its world share, 1 worksChemical EngineeringChemistry: 1.56× its world share, 15 worksChemistryComputer Science: 0.31× its world share, 15 worksComputer ScienceEarth and Planetary Sciences: 0.02× its world share, 0 worksEarth and Planetary …Engineering: 0.22× its world share, 21 worksEngineeringEnvironmental Science: 0.20× its world share, 6 worksEnvironmental ScienceMaterials Science: 0.39× its world share, 8 worksMaterials ScienceMathematics: 5.19× its world share, 38 worksMathematicsPhysics and Astronomy: 0.03× its world share, 0 worksPhysics and AstronomyDentistry: 0.07× its world share, 0 worksDentistryHealth Professions: 0.58× its world share, 10 worksHealth ProfessionsMedicine: 2.35× its world share, 282 worksMedicineNursing: 0.43× its world share, 1 worksNursingVeterinary: 3.11× its world share, 3 worksVeterinaryArts and Humanities: 0.03× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.10× its world share, 2 worksBusiness, Management…Decision Sciences: 1.29× its world share, 8 worksDecision SciencesEconomics, Econometrics and Finance: 2.38× its world share, 32 worksEconomics, Econometr…Psychology: 0.27× its world share, 5 worksPsychologySocial Sciences: 0.06× its world share, 4 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 23.3×. Every wedge is a field page.

Who are the top researchers at Center for Drug Evaluation and Research?

Ranked on the composite score, Janet Woodcock, Robert Temple and Baolin Zhang lead among researchers whose main affiliation is Center for Drug Evaluation and Research.

  1. 1 Janet Woodcock United States · #81,027 worldwide 211 citations · 30 works
  2. 2 Robert Temple United States · #199,099 worldwide 135 citations · 27 works
  3. 3 Baolin Zhang United States · #205,697 worldwide 126 citations · 26 works
  4. 4 Shiew‐Mei Huang United States · #387,715 worldwide 93 citations · 33 works
  5. 5 Yaqin Zhang United States · #407,480 worldwide 101 citations · 30 works
  6. 6 Xinyuan Zhang United States · #441,264 worldwide 76 citations · 21 works
  7. 7 Mark Avigan United States · #493,637 worldwide 76 citations · 16 works
  8. 8 Susan Gruber United States · #493,789 worldwide 58 citations · 21 works
  9. 9 Mei‐Ling Chen United States · #499,589 worldwide 88 citations · 19 works
  10. 10 Mansoor A. Khan United States · #501,163 worldwide 179 citations · 67 works
All ranked researchers at Center for Drug Evaluation and Research

Which keywords describe research at Center for Drug Evaluation and Research?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Biomarkers, Bayesian Methods, Monoclonal Antibodies, Adverse Drug Reactions, Adaptive Designs, False Discovery Rate and Medication Adherence.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Clinical Trials42▲ 9.9×16 topics
  2. Biomarkers36▲ 8.4×14 topics
  3. Epidemiology34▲ 1.37×82 topics
  4. Bayesian Methods28▲ 91×2 topics
  5. Monoclonal Antibodies28▲ 50×3 topics
  6. Adverse Drug Reactions27▲ 82×2 topics
  7. Adaptive Designs26▲ 206×1 topic
  8. False Discovery Rate26▲ 206×1 topic
  9. Quality of Life24▲ 2.6×18 topics
  10. Medication Adherence22▲ 64×2 topics
  11. Biopharmaceuticals21▲ 66×3 topics
  12. Oxidative Stress21▲ 2.0×37 topics
  13. Immunogenicity20▲ 77×3 topics
  14. Pharmacokinetics20▲ 12×10 topics
  15. Drug Development20▲ 36×3 topics
  16. Nanoparticles19▲ 2.4×17 topics
  17. Off-Label Drug Use18▲ 110×1 topic
  18. Pediatric Pharmacokinetics18▲ 110×1 topic
  19. Cost-effectiveness Analysis17▲ 32×1 topic
  20. Economic Evaluation17▲ 23×2 topics
  21. Health Utility Measures17▲ 32×1 topic
  22. Immunotherapy16▲ 3.6×17 topics
  23. Therapeutic Antibodies16▲ 36×2 topics
  24. Chemotherapy16▲ 3.5×21 topics
  25. Pharmaceutical Industry14▲ 61×2 topics
  26. Glycosylation13▲ 19×3 topics
  27. Clinical Outcomes13▲ 9.7×5 topics
  28. Bioanalytical Methods12▲ 97×1 topic
  29. Biosimilars12▲ 97×1 topic
  30. Genetic Variation11▲ 8.2×6 topics
  31. Medicinal Chemistry11▲ 6.3×5 topics
  32. Molecular Docking10▲ 13×2 topics
  33. Drug Development Costs10▲ 64×1 topic
  34. Generic Drugs10▲ 64×1 topic
  35. Polymeric Materials10▲ 24×2 topics
  36. Cyclodextrins10▲ 82×1 topic
  37. Solid Dispersions10▲ 82×1 topic
  38. Targeted Therapy10▲ 7.3×5 topics
  39. Publication Bias9▲ 32×3 topics
  40. Drug Target Identification9▲ 16×1 topic

Which research topics does Center for Drug Evaluation and Research publish most on?

By volume in 2022–2025: Statistical Methods in Clinical Trials, Pharmaceutical studies and practices, Health Systems, Economic Evaluations, Quality of Life and Biosimilars and Bioanalytical Methods.

  1. 1 Statistical Methods in Clinical Trials Statistics and Probability 26 works
  2. 2 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 18 works
  3. 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 17 works
  4. 4 Biosimilars and Bioanalytical Methods Immunology 12 works
  5. 5 Pharmaceutical Economics and Policy Economics and Econometrics 10 works
  6. 6 Drug Solubulity and Delivery Systems Pharmaceutical Science 10 works
  7. 7 Computational Drug Discovery Methods Computational Theory and Mathematics 9 works
  8. 8 Pharmacovigilance and Adverse Drug Reactions Toxicology 9 works
  9. 9 Pharmacogenetics and Drug Metabolism Pharmacology 9 works
  10. 10 Protein purification and stability Molecular Biology 8 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.9%not open64.1%

World: 28% of research is openly available.

with international co-authors13.1%domestic only86.9%

World: 19% is written across borders.

How has Center for Drug Evaluation and Research's research output changed?

Output in 2018–2022 was 15% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Silver Spring

All research institutions in Silver Spring

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.